Honokiol alleviates sepsis-associated cardiac dysfunction via attenuating inflammation, apoptosis and oxidative stress.
暂无分享,去创建一个
[1] I. Meral,et al. A low direct electrical signal attenuates oxidative stress and inflammation in septic rats , 2021, PloS one.
[2] Qing-Wen Zhang,et al. Honokiol: A naturally occurring lignan with pleiotropic bioactivities. , 2021, Chinese journal of natural medicines.
[3] S. Omari Shekaftik,et al. 8-Hydroxy-2′-deoxyguanosine (8-OHdG) as a biomarker of oxidative DNA damage induced by occupational exposure to nanomaterials: a systematic review , 2021, Nanotoxicology.
[4] Bo Zhang,et al. LncRNA NR024118 is downregulated in sepsis and inhibits LPS-induced apoptosis of cardiomyocytes , 2021, Molecular medicine reports.
[5] D. Tang,et al. Inflammasome-Dependent Coagulation Activation in Sepsis , 2021, Frontiers in Immunology.
[6] Srinivas Gopala,et al. Honokiol regulates mitochondrial substrate utilization and cellular fatty acid metabolism in diabetic mice heart. , 2021, European journal of pharmacology.
[7] M. Singer,et al. Pathophysiology of sepsis-induced cardiomyopathy , 2021, Nature Reviews Cardiology.
[8] G. Askari,et al. The role of phytochemicals in sepsis: A mechanistic and therapeutic perspective , 2020, BioFactors.
[9] Andy Y. An,et al. Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities , 2020, EBioMedicine.
[10] Sang Yoon Lee,et al. Honokiol ameliorates angiotensin II‐induced hypertension and endothelial dysfunction by inhibiting HDAC6‐mediated cystathionine γ‐lyase degradation , 2020, Journal of cellular and molecular medicine.
[11] M. Wurfel,et al. Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness , 2020, EBioMedicine.
[12] Nirmala Grace Andrews,et al. Honokiol-camptothecin loaded graphene oxide nanoparticle towards combinatorial anti-cancer drug delivery. , 2020, IET nanobiotechnology.
[13] C. Shih,et al. Low-dose hydralazine improves endotoxin-induced coagulopathy and multiple organ dysfunction via its anti-inflammatory and anti-oxidative/nitrosative properties. , 2020, European journal of pharmacology.
[14] P. Xing,et al. LncRNA MIAT Promotes Inflammation and Oxidative Stress in Sepsis-Induced Cardiac Injury by Targeting miR-330-5p/TRAF6/NF-κB Axis , 2020, Biochemical Genetics.
[15] Weiwei Yu,et al. Crocetin Attenuates Sepsis-Induced Cardiac Dysfunction via Regulation of Inflammatory Response and Mitochondrial Function , 2020, Frontiers in Physiology.
[16] A. Khanna,et al. Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making. , 2020, The Medical clinics of North America.
[17] Ahmed Labib. Sepsis Care Pathway 2019 , 2019, Qatar medical journal.
[18] D. Kouvelas,et al. Dexmedetomidine effects in different experimental sepsis in vivo models. , 2019, European journal of pharmacology.
[19] L. Xiang,et al. Honokiol alleviates sepsis-induced acute kidney injury in mice by targeting the miR-218-5p/heme oxygenase-1 signaling pathway , 2019, Cellular & Molecular Biology Letters.
[20] Yuxiao Sun,et al. Cardiac Autophagy in Sepsis , 2019, Cells.
[21] Han Liu,et al. Honokiol Attenuates Sepsis-Associated Acute Kidney Injury via the Inhibition of Oxidative Stress and Inflammation , 2019, Inflammation.
[22] Y. Mabkhot,et al. Honokiol: An anticancer lignan. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[23] Peng Li,et al. Alamandine attenuates sepsis‐associated cardiac dysfunction via inhibiting MAPKs signaling pathways , 2018, Life sciences.
[24] Li Li,et al. [Advances in biomarkers of myocardial injury in sepsis]. , 2018, Zhonghua wei zhong bing ji jiu yi xue.
[25] Jian Yang,et al. Honokiol Ameliorates Myocardial Ischemia/Reperfusion Injury in Type 1 Diabetic Rats by Reducing Oxidative Stress and Apoptosis through Activating the SIRT1-Nrf2 Signaling Pathway , 2018, Oxidative medicine and cellular longevity.
[26] C. Coopersmith,et al. Honokiol Increases CD4+ T Cell Activation and Decreases TNF but Fails to Improve Survival Following Sepsis , 2017, Shock.
[27] Kai Huang,et al. Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts , 2017, Scientific Reports.
[28] T. Schürholz,et al. Herz in der Sepsis , 2017, Der Anaesthesist.
[29] F. Siemers,et al. Continuous Hemoadsorption with a Cytokine Adsorber during Sepsis – a Review of the Literature , 2017, The International journal of artificial organs.
[30] J. Arbiser,et al. Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice , 2017, Oncotarget.
[31] M. Chu,et al. Butyrate pretreatment attenuates heart depression in a mice model of endotoxin‐induced sepsis via anti‐inflammation and anti‐oxidation , 2017, The American journal of emergency medicine.
[32] Dean P. Jones,et al. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3 , 2015, Nature Communications.
[33] Shing-Hwa Liu,et al. Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation , 2011, Intensive Care Medicine.
[34] S-X Qi,et al. LncRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-κB signaling pathway. , 2019, European review for medical and pharmacological sciences.